1.Frequency of Killer Cell Immunoglobulin-like Receptors (KIRs) in Korean Patients with Chronic HCV Infection.
Pil Soo SUNG ; Hee Baeg CHOI ; Su Yeon KIM ; Sung Woo HONG ; Chung Hwa PARK ; Myeong Jun SONG ; Sung Won LEE ; Chan Ran YOO ; Sang Wook CHOI ; Nam Ik HAN ; Tai Gyu KIM ; Seung Kew YOON
Journal of Korean Medical Science 2011;26(11):1483-1488
Natural killer (NK) cells play an important role in innate immunity, especially in the response to viral infections, such as hepatitis C virus (HCV). Killer cell immunoglobulin-like receptors (KIRs) are the primary receptors of NK cells that mediate innate immunity. KIRs are also involved in acquired immunity, because some KIRs are expressed on the surface of certain subsets of T cells. In this study, the frequency of KIR genes, HLA-C allotypes, and combinations of KIR genes with their HLA-C ligands were evaluated in two different groups of the Korean population: controls and patients with chronic HCV infection. The study population consisted of 147 Korean patients with chronic HCV infection. The frequency of KIR2DS2 in patients with chronic HCV infection was 9.5% which was significantly lower than 19.5% of the control (P < 0.01). However, there were no significant differences in the frequency of other KIR genes, HLA-C allotypes or different combinations of KIR genes with their HLA-C ligands. This study can contribute to the further prospective study with a larger scale, suggesting the assumption that KIR2DS2 might aid in HCV clearance by enhancing both the innate and acquired immune responses of people in Korea.
Adult
;
Aged
;
Female
;
Genes, MHC Class I
;
Genotype
;
HLA-C Antigens/genetics
;
Hepacivirus/immunology
;
Hepatitis C, Chronic/*genetics/immunology
;
Humans
;
Killer Cells, Natural/immunology/virology
;
Male
;
Middle Aged
;
Receptors, KIR/*genetics/immunology
;
Republic of Korea
;
T-Lymphocyte Subsets/immunology
2.Evaluation of ARCHITECT HCV Core Antigen Assay.
Dual SONG ; Jeong Eun KANG ; Shine Young KIM ; Sang Hyun HWANG ; Hyung Hoi KIM ; Eun Yup LEE ; Han Chul SON
The Korean Journal of Laboratory Medicine 2010;30(6):654-659
BACKGROUND: Hepatitis C virus (HCV) core antigen (Ag) levels are known to be well correlating with HCV RNA levels, and may be used as an alternative marker of HCV replication for monitoring the response to HCV treatment. However, the low sensitivity of HCV core Ag assay has been an obstacle for clinical use. In this study, recently developed ARCHITECT HCV Ag assay (Abbott Laboratories, USA) was evaluated for analytical performance and clinical usefulness. METHODS: A total of 109 sera from HCV infected patients including various genotypes of HCV (1b, 2, 2a/2c, 2b, and 3a) and 20 sera from healthy donors were used for evaluating the sensitivity, precision, and linearity of the HCV core Ag assay. The cross reactivity with HIV, hepatitis B virus and myeloma proteins (N=5, each) and correlation with HCV RNA PCR assay were also evaluated. RESULTS: The sensitivity of the HCV core Ag assay was 97.2% (106/109) and there were no false positive results and cross reactivity. The within-run, between-run and between-day CVs were 3.0%, 2.5% and 3.0%, respectively. The levels of HCV core antigen showed a good correlation with those of HCV RNA quantification (r=0.940). The HCV Ag assay showed an excellent linearity in the range from 0.63 to 17,114 fmol/L (r=0.999). CONCLUSIONS: The ARCHITECT HCV Ag assay was good in sensitivity, precision, and linearity and its results well correlated with HCV RNA levels. This assay could be used as a good marker of viral replication for monitoring the therapy response in chronically HCV infected patients.
Chemiluminescent Measurements/*methods
;
Cross Reactions
;
Genotype
;
Hepacivirus/genetics/*immunology
;
Hepatitis Antigens/*blood
;
Humans
;
Polymerase Chain Reaction/*methods
;
RNA, Viral/blood
;
Reagent Kits, Diagnostic
;
Sensitivity and Specificity
;
Viral Core Proteins/*blood
3.New Therapeutic Agent for Chronic Hepatitis C: Direct Acting Agent.
The Korean Journal of Gastroenterology 2015;66(1):5-9
Peg-interferon and ribavirin has been the standard therapy of chronic hepatitis C for the past 15 years in Korea. However, the treatment paradigm is changing. Direct acting agents (DAAs) are oral pills that can be easily taken. In addition, DAAs are more effective and have less adverse reactions compared to the previously used drugs. Chronic hepatitis C is hard to treat because the virus is error-prone virus. Host immunity is helpless against the hepatitis C virus since it evades the host immunity through various complex mechanisms. There are 6 genotypes. Quasispecies can co-exist even in the same patients. The treatment strategy is based on the combination of the individual drug corresponding to each step of viral replication process. NS5B nucleosides are the most powerful and effective drug available until now. Other drugs with different mechanisms of action can be used to provide synergy. NS5A and NS5B inhibition drugs currently belong to the leading group amongst many DAAs. These drugs will soon be available in Korea. We have to know the merits and adverse drug reactions of the new drug.
Antiviral Agents/*therapeutic use
;
Drug Therapy, Combination
;
Enzyme Inhibitors/therapeutic use
;
Genotype
;
Guidelines as Topic
;
Hepacivirus/genetics
;
Hepatitis C, Chronic/*drug therapy/immunology/virology
;
Humans
;
Viral Nonstructural Proteins/antagonists & inhibitors/metabolism
4.A case: control study on the risk factors of hepatitis C virus infection among Koreans.
Young Sik KIM ; Yoon Ok AHN ; Dae Won KIM
Journal of Korean Medical Science 1996;11(1):38-43
In order to identify the risk factors for hepatitis C virus (HCV) infections, a case-control study was conducted from September 1993 to April 1994. HCV infection was confirmed by the second generation of recombinant immunoblot assay. Sixty-four cases and 128 controls matched for age and sex with a 1:2 ratio of cases to controls were enrolled. Exposure data were obtained from all participants by self-administered questionnaire and the odds ratios of possible risk factors of HCV infection analysed. Sixty-four cases consisted of forty-two patients with chronic hepatitis, nine with cirrhosis, one with hepatocellular carcinoma, and twelve with normal liver function. History of acute hepatitis (OR 3.9) and transfusion (OR 2.4) were associated with an increased risk of HCV infection. Operation, acupuncture, endoscopy, tooth extraction, tattooing, ear piercing, needle sharing and family history of hepatitis were not associated with an increased risk of HCV infection. In conclusion, transfusion remains the major route of transmission of HCV in Korea.
Adult
;
Base Sequence
;
Case-Control Studies
;
DNA, Viral/analysis
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Hepacivirus/genetics/immunology/isolation & purification
;
Hepatitis C/*epidemiology/immunology/virology
;
Hepatitis C Antibodies/blood
;
Human
;
Male
;
Middle Age
;
Molecular Sequence Data
;
Predictive Value of Tests
;
Risk Factors
;
Support, Non-U.S. Gov't